Short Bowel Syndrome (SBS) Drugs Report

By www.marketgrowthrate.com

Report Details

Report Name

Global Short Bowel Syndrome (SBS) Drugs Market Research Report 2024 Story

Pages

89

Price

$ 2900

Features

Short Bowel Syndrome (SBS) Drugs Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma